What does PRAC stand for?

Pyrethrum Research Advisory Committee

Practice and Research: Advancing Collaboration

Pharmacovigilance Risk Assessement Committee

Pharmacovigilance and Risk Assessment Committee

The Pharmacovigilance and Risk Assessment Committee (PRAC) plays a pivotal role in the medical field, focusing on the evaluation of risks associated with medicinal products. It ensures that the benefits of medications outweigh their potential risks, safeguarding public health. The committee's work involves continuous monitoring, assessment, and communication of safety information to healthcare professionals and patients.

The PRAC's responsibilities extend to recommending measures to minimize risks, including updates to product information or restrictions in use. Its decisions are based on thorough scientific evaluation, incorporating data from clinical trials and post-marketing surveillance. The committee's efforts are crucial in maintaining trust in the pharmaceutical industry and ensuring patient safety across the European Union.